PortalPublikationenDifferential 3-year effects of first- versus second-generati...

Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models.

Standard

Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models. / Lambert, Martin; Schimmelmann, Benno G; Schacht, Alexander; Suarez, David; Haro, Josep Maria; Novick, Diego; Wagner, Thomas; Wehmeier, Peter M; Huber, Christian; Hundemer, Hans-Peter; Dittmann, Ralf W; Naber, Dieter.

in: J CLIN PSYCHOPHARM, Jahrgang 31, Nr. 2, 2, 2011, S. 226-230.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Lambert, M, Schimmelmann, BG, Schacht, A, Suarez, D, Haro, JM, Novick, D, Wagner, T, Wehmeier, PM, Huber, C, Hundemer, H-P, Dittmann, RW & Naber, D 2011, 'Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models.', J CLIN PSYCHOPHARM, Jg. 31, Nr. 2, 2, S. 226-230. <http://www.ncbi.nlm.nih.gov/pubmed/21346606?dopt=Citation>

APA

Lambert, M., Schimmelmann, B. G., Schacht, A., Suarez, D., Haro, J. M., Novick, D., Wagner, T., Wehmeier, P. M., Huber, C., Hundemer, H-P., Dittmann, R. W., & Naber, D. (2011). Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models. J CLIN PSYCHOPHARM, 31(2), 226-230. [2]. http://www.ncbi.nlm.nih.gov/pubmed/21346606?dopt=Citation

Vancouver

Lambert M, Schimmelmann BG, Schacht A, Suarez D, Haro JM, Novick D et al. Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models. J CLIN PSYCHOPHARM. 2011;31(2):226-230. 2.

Bibtex

@article{b95967153edd417699976c3cca32e8d2,
title = "Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models.",
abstract = "This study examined the differential effects of first- (FGAs) versus second-generation antipsychotics (SGAs) on subjective well-being in patients with schizophrenia.",
keywords = "Adult, Humans, Male, Female, Middle Aged, Prospective Studies, Follow-Up Studies, *Models, Biological, Antipsychotic Agents/*therapeutic use, *Schizophrenic Psychology, *Patient Satisfaction, Schizophrenia/*drug therapy, Adult, Humans, Male, Female, Middle Aged, Prospective Studies, Follow-Up Studies, *Models, Biological, Antipsychotic Agents/*therapeutic use, *Schizophrenic Psychology, *Patient Satisfaction, Schizophrenia/*drug therapy",
author = "Martin Lambert and Schimmelmann, {Benno G} and Alexander Schacht and David Suarez and Haro, {Josep Maria} and Diego Novick and Thomas Wagner and Wehmeier, {Peter M} and Christian Huber and Hans-Peter Hundemer and Dittmann, {Ralf W} and Dieter Naber",
year = "2011",
language = "English",
volume = "31",
pages = "226--230",
journal = "J CLIN PSYCHOPHARM",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models.

AU - Lambert, Martin

AU - Schimmelmann, Benno G

AU - Schacht, Alexander

AU - Suarez, David

AU - Haro, Josep Maria

AU - Novick, Diego

AU - Wagner, Thomas

AU - Wehmeier, Peter M

AU - Huber, Christian

AU - Hundemer, Hans-Peter

AU - Dittmann, Ralf W

AU - Naber, Dieter

PY - 2011

Y1 - 2011

N2 - This study examined the differential effects of first- (FGAs) versus second-generation antipsychotics (SGAs) on subjective well-being in patients with schizophrenia.

AB - This study examined the differential effects of first- (FGAs) versus second-generation antipsychotics (SGAs) on subjective well-being in patients with schizophrenia.

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Prospective Studies

KW - Follow-Up Studies

KW - Models, Biological

KW - Antipsychotic Agents/therapeutic use

KW - Schizophrenic Psychology

KW - Patient Satisfaction

KW - Schizophrenia/drug therapy

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Prospective Studies

KW - Follow-Up Studies

KW - Models, Biological

KW - Antipsychotic Agents/therapeutic use

KW - Schizophrenic Psychology

KW - Patient Satisfaction

KW - Schizophrenia/drug therapy

M3 - SCORING: Journal article

VL - 31

SP - 226

EP - 230

JO - J CLIN PSYCHOPHARM

JF - J CLIN PSYCHOPHARM

SN - 0271-0749

IS - 2

M1 - 2

ER -